This is further supported by the observation that in individual patient samples in which this treatment failed to reduce the size of the AR+ population, the frequency of CLL cells showing signs of apoptosis was unchanged compared to untreated and DMSO-treated samples. This evidence concerns the gene AR and B-cell chronic lymphocytic leukemia.